700 related articles for article (PubMed ID: 26153093)
1. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
3. The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma.
Huang YC; Chen MF; Shi CS; Shindel AW; Huang CE; Pang ST; Chuang CK; Chen CS; Chang YH; Lin WY; Ho DR; Chin CC; Kuo YH; Wu CF
J Urol; 2015 Aug; 194(2):323-9. PubMed ID: 25796114
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association.
Hara T; Fujimoto H; Sakura M; Inokuchi J; Nishiyama H; Miyazaki J; Ohyama C; Koie T; Kikuchi E; Hinotsu S;
Int J Urol; 2015 Nov; 22(11):1013-20. PubMed ID: 26242807
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
Liu W; Zhou Z; Dong D; Sun L; Zhang G
Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients With Upper Tract Urothelial Carcinoma.
Milojevic B; Dzamic Z; Kajmakovic B; Durutovic O; Bumbasirevic U; Sipetic Grujicic S
Clin Genitourin Cancer; 2015 Oct; 13(5):485-91. PubMed ID: 25920995
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.
Fujita K; Tanigawa G; Imamura R; Nakagawa M; Hayashi T; Kishimoto N; Hosomi M; Yamaguchi S
Int J Urol; 2013 Jun; 20(6):594-601. PubMed ID: 23131052
[TBL] [Abstract][Full Text] [Related]
9. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.
Yafi FA; Tanguay S; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Lacombe L; Chin J; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Kassouf W
Urol Oncol; 2014 Jan; 32(1):31.e17-24. PubMed ID: 23428535
[TBL] [Abstract][Full Text] [Related]
11. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
[TBL] [Abstract][Full Text] [Related]
12. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.
Tanaka N; Kikuchi E; Shirotake S; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Ito Y; Kosaka T; Kodaira K; Oyama M; Miyajima A; Momma T; Nakagawa K; Ueno M; Oya M
Eur Urol; 2014 Jan; 65(1):227-34. PubMed ID: 23219372
[TBL] [Abstract][Full Text] [Related]
14. Selected High-Risk Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy for Adjuvant Chemotherapy: A Multi-Institutional Retrospective Study.
Ikeda M; Matsumoto K; Hirayama T; Koguchi D; Murakami Y; Matsuda D; Okuno N; Utsunomiya T; Taoka Y; Irie A; Iwamura M
Clin Genitourin Cancer; 2018 Jun; 16(3):e669-e675. PubMed ID: 29239844
[TBL] [Abstract][Full Text] [Related]
15. Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Aziz A; Rink M; Gakis G; Kluth LA; Dechet C; Miller F; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Fisch M; Burger M; Fritsche HM
Urol Int; 2014; 93(3):352-60. PubMed ID: 25138778
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of the preoperative serum albumin : globulin ratio after radical nephroureterectomy for upper tract urothelial carcinoma.
Otsuka M; Kamasako T; Uemura T; Takeshita N; Shinozaki T; Kobayashi M; Komaru A; Fukasawa S
Int J Urol; 2018 Oct; 25(10):871-878. PubMed ID: 30103271
[TBL] [Abstract][Full Text] [Related]
17. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
18. Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma.
Tsuzuki S; Kimura S; Fukuokaya W; Yanagisawa T; Hata K; Miki J; Kimura T; Abe H; Egawa S
Jpn J Clin Oncol; 2021 Jan; 51(1):138-144. PubMed ID: 32728722
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
Hellenthal NJ; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Bolenz C; Remzi M; Weizer A; Zigeuner R; Bensalah K; Ng CK; Raman JD; Kikuchi E; Montorsi F; Oya M; Wood CG; Fernandez M; Evans CP; Koppie TM
J Urol; 2009 Sep; 182(3):900-6. PubMed ID: 19616245
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
Kuroda K; Asakuma J; Horiguchi A; Tasaki S; Yoshii H; Sato A; Ito K; Seguchi K; Sumitomo M; Asano T
Urol Int; 2012; 88(2):225-31. PubMed ID: 22236640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
